Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DefenCath vs Standard of Care for CRBSI in Pediatric Hemodialysis Patients
NCT06714864Phase 4Recruiting
- Sponsor
- CorMedix Inc.
- Start
- Jul 2025
- Primary completion
- Jul 2028
- Modality
- Pharmaceutical
- Countries
- 1
01
Overview
A Phase 4 trial of Heparina cálcica in Catheter-related infection (CRI), sponsored by CorMedix Inc.. Started Jul 2025; status: recruiting.
02
Drugs
Heparina cálcica
03
Conditions
Catheter-related infection (CRI)
Beyond the preview
Go deeper on NCT06714864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06714864.